OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS von Dokukina, T.V., Makhrov, M.V., Gaidukevich, I.V., Gilep, A.A., Golubeva, T.S., Khlebokazov, F.P., Misyuk, N.N., Korolevich, P.P.

Volltext